Severe sclerokeratitis due to Pseudomonas aeruginosa in non-contact-lens wearers

Eye

Volumn 14, Issue 1, 2000, Pages 3-7

  Radford, R ^a   Brahma, A ^a   Armstrong, M ^b   Tullo, A B ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cefuroxime; Conjunctiva; Cornea; Gentamicin; Pseudomonas aeruginosa

Indexed keywords

ACETAZOLAMIDE; AMOXICILLIN; ANTIBIOTIC AGENT; ATROPINE; CEFUROXIME; CHLORAMPHENICOL; FLURBIPROFEN; GENTAMICIN; LEVOBUNOLOL; METRONIDAZOLE; OFLOXACIN; PREDNISOLONE; STEROID; TICARCILLIN;

ADULT; AGED; ANTERIOR EYE SEGMENT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTACT LENS; CORNEA THICKNESS; GRAM NEGATIVE INFECTION; HUMAN; KERATITIS; LUNG TUBERCULOSIS; PERSISTENT INFECTION; PSEUDOMONAS AERUGINOSA; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0034051177     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.2000.2     Document Type: Article

References (25)

1. Helm CJ, Holland GN, Robert G, et al. Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis. Ophthalmology 1997;104:838-43.
2. Lotti R, Dart JKG. Cataract as a complication of severe microbial keratitis. Eye 1992;6:400-3.
3. Moriarty AP, Crawford GJ, McAllaster IL, Constable IJ. Severe corneoscleral infection: a complication of beta irradiation scleral necrosis following pterygium excision. Arch Ophthalmol 1993;111:947-51.
4. Rubifleld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium removal. Ophthalmology 1992;99:1647-54.
5. Hsiao CH, Chen JY, Haung SCM, Ma HK, Chen PYF, Tsai RJF. Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol 1998;82:29-34.
6. Schein OD, Wasson PJ. Microbial keratin's associates with contaminated ocular medications. Am J Ophthalmol 1988;105:361-5.
7. Alfonso E, Kenyon KR, Ormerod LD, et al. Pseudomonas corneoscleritis. Am J Ophthalmol 1987;103:90-8.
8. Schein OD, Hibbard PL, Starck T, Baker AS, et al. Microbial contamination of in-use ocular medications. Arch Ophthalmol 1992;110:82-5.
9. Pepose JS, Holland GN, Wilhelmus KR. Ocular infection and immunity. St Louis: Mosby, 1996:202-5.
10. Lochater-Khoranzo D, Gutierrez D. The bacterial flora of the healthy eye. In: Microbiology of the eye. St Louis: Mosby-Year Book, 1977:14-7.
11. Allison JS, Dawson M, Drake D, Montie TC. Electrophoretic separation and molecular weight characterisation of Pseudomonas aeruginosa H-antigen flagellin. Infect Immun 1985;49:770-4.
12. Davis DG, Parsek RM, Pearson JP, Iglewiski BH, Costerton JW, Greenberg P. The involvement of cell to cell signals in the development of bacterial biofilms. Science 1998;280:295-8.
13. McLaughlin-Borlace L, Stapleton F, Matheson M, Dark JK. Bacterial biofilm on contact lenses and storage cases in wearers with microbial keratitis. J Appl Microbiol 1998;84:827-38.
14. Dua HS. Bacterial keratitis in the critically ill and comatose patient. Lancet 1998;351:387-8.
15. Masinick SA, Montgomery CP, Montgomery PC, Hazlett LD. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis. Invest Ophthalmol Vis Sci 1997;38:910-8.
16. McClellan KA. Mucosal defence of the outer eye. Surv Ophthalmol 1997;42:233-46.
17. Ramphal R, McNiece MT, Polack FM. Adherence of Pseudomonas aeruginosa to the injured cornea: a step in the pathogenesis of corneal infections. Ann Ophthalmol 1981;13:421-5.
18. Gupta SK, Masinik SA, Hobden JA, Berk RS, Hazlett LD. Bacterial proteases and adherence of Pseudomonas aeruginosa to mouse cornea. Exp Eye Res 1996;62:641-50.
19. Engel L, Hill JM, Moreau JM, Green LC, et al. Protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci 1998;39:662-5.
20. Steuhl KP, Doring G, Thiel HJ. Relevance of host derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Invest Ophthalmol Vis Sci 1987;28:1559-68.
21. Kernacki A, Goebal MS, Hazlett P, Hazlett LD. Early TIMP gene expression after corneal infection with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 1998;39:331-5.
22. Gachon A-MF, Lacazette E. Tear lipocalin and the eye's front line of defence. Br J Ophthalmol 1998;32:453-5.
23. Harben T. Recurrence of corneal Pseudomonas infection after topical steroid therapy: report of a case. Am J Ophthalmol 1964;58:670-4.
24. The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomised, controlled trial with conventional dual therapy. Ophthalmology 1997;104:1902-9.
25. Celebi S, Ay S, Aykan U, Bulut V, Alagoz G, Celiker UO. Penetration of oral and topical ciprofloxacin into human aqueous humor. Acta Ophthalmol Scand 1998;76:683-5.